BRD-K09008126-001-01-6 (Substance)

Compound:

(1R,2aR,8bR)-N-(2-chlorophenyl)-1-(hydroxymethyl)-4-(pyridine-4-carbonyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

Compound (Entity type)

Synonyms:BRD-K09008126-001-01-6

Id:131450047

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K09008126-001-01-6's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 PBIOA006 XC.L10 24H H04 BRD-K09008126 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA006 XC.R10 24H H04 BRD-K09008126 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA006 XC.L10 24H H05 BRD-K09008126 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA006 XC.L10 24H H06 BRD-K09008126 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA006 XC.R10 24H H05 BRD-K09008126 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 PBIOA006 XC.R10 24H H06 BRD-K09008126 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project